✦ LIBER ✦

Changing the outcome of osteoarthritis: Still a challenge for cyclooxygenase 2 inhibitors

✍ Scribed by Rik J. U. Lories

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 40 KB
Volume: 64
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.33330

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Need for common internal controls when a

Need for common internal controls when assessing the relative efficacy of pharmacologic agents using a meta-analytic approach: Case study of cyclooxygenase 2-selective inhibitors for the treatment of osteoarthritis

✍ Lee, Chin ;Hunsche, Elke ;Balshaw, Robert ;Kong, Sheldon X. ;Schnitzer, Thomas J 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 3 views

Comparing the efficacy of cyclooxygenase

Comparing the efficacy of cyclooxygenase 2–specific inhibitors in treating osteoarthritis: Appropriate trial design considerations and results of a randomized, placebo-controlled trial

✍ Allan Gibofsky; Gary W. Williams; Frank McKenna; John G. Fort 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

Comparison of the effect of rofecoxib (a

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial

✍ Christopher Hawkey; Loren Laine; Thomas Simon; Andre Beaulieu; Jose Maldonado-Co 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

Rofecoxib, a specific inhibitor of cyclo

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip

✍ Grant W. Cannon; Jacques R. Caldwell; Peter Holt; Barry McLean; Beth Seidenberg; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views